Tricida Announces FDA Acceptance of New Drug Application for Veverimer

5 years ago

by David Miller

953 Views

Written by David Miller

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Nov. 14, 2019– Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed,…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!